Spyre Therapeutics, Inc. (SYRE)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$88.98+1.98%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · SYRE
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | |||||||||||
| Revenues | — | — | — | 0.9 | 2.3 | 18.7 | 0.0 | 0.0 | 3.9 | — | — |
| Operating Expenses & Income | |||||||||||
| R&D Expenses | — | — | — | — | 58.6 | 57.1 | 59.6 | 64.6 | 36.7 | 22.8 | 18.1 |
| Operating Income | (201.3) | (209.6) | (208.6) | (242.3) | (84.8) | (65.6) | (81.5) | (80.3) | (45.5) | (27.7) | (21.9) |
| Earnings from Continuing Operations | |||||||||||
| Other Non-Operating Income / Expenses | 22.4 | 54.3 | 0.6 | (96.5) | 0.8 | (0.0) | 0.6 | 2.1 | 1.1 | 0.4 | 0.2 |
| Asset Writedown | — | — | — | 2.6 | 0.0 | 0.0 | — | — | — | — | — |
| EBT, Incl. Unusual Items | (178.9) | (155.2) | (208.0) | (338.8) | (84.0) | (65.7) | (80.9) | — | — | — | — |
| Income Tax Expense | — | (0.0) | 0.1 | (0.0) | (0.1) | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Income | |||||||||||
| Net Income | (178.9) | (155.2) | (208.0) | (338.8) | (83.8) | (65.8) | (80.9) | (78.3) | (44.3) | (27.2) | (21.7) |
| Per Share | |||||||||||
| Basic EPS | — | — | — | 13.76 | (24.86) | (25.02) | (1.52) | — | — | — | — |
| Diluted EPS | — | — | — | 13.76 | (24.86) | (25.02) | (1.52) | — | — | — | — |
| Basic Weighted Avg Shares | — | — | — | 6.9 | 3.4 | 2.6 | 53.4 | — | — | — | — |
| Diluted Weighted Avg Shares | — | — | — | 6.9 | 3.4 | 2.6 | 53.4 | — | — | — | — |
| Supplemental | |||||||||||
| EBITDA | — | — | — | (241.6) | (83.2) | (64.1) | (80.5) | (79.9) | (45.2) | (27.4) | (21.8) |
| EBIT | (201.3) | (209.6) | (208.6) | (242.3) | (84.8) | (65.6) | (81.5) | (80.3) | (45.5) | (27.7) | (21.9) |
| Effective Tax Rate | — | — | — | 0.0% | 0.2% | -0.2% | 0.0% | — | — | — | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.